Form 4 for DRIO DarioHealth Corp.
Accepted 2025-09-15 00:00:00 ET · period of report 2025-09-11 · accession 0001104659-25-090006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-15 | 2025-09-11 | DRIO | Raphael Erez | CEO, Dir | A - Grant | $0.00 | +60.0K | 156.9K | +62% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-11 | A | A | 60,000 | $0.00 | 156,853 | D | — | — | (F1) The restricted share award shall vest in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period. (F2) The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025. |